http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19960154-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d32a49211015b18ecef5a3a5195bf06e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
filingDate 1999-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68585b1660fd79bc9db2960abe5bd25b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fe8af35a0be25eb854d73e10ed60b3e
publicationDate 2001-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-19960154-A1
titleOfInvention Flat pharmaceutical preparation for transmucosal administration of oxycodone or a comparable active ingredient in the oral cavity, for use in pain therapy and addiction therapy
abstract A flat, film-like, film-like, paper-like or wafer-shaped medicinal preparation which can be disintegrated in aqueous media for the transmucosal administration of active substances in the oral cavity is characterized by a content of oxycodone, or an active substance comparable to oxycodone, or a therapeutically suitable salt of oxycodone or of the pharmacologically comparable active ingredient.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102005007859-A1
priorityDate 1999-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19652188-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9715294-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0171742-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8809676-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493286
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491270
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507804
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9848990
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284596
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507876
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426326933
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426120401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6850753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5283468
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359421
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407124392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416053110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505278

Total number of triples: 52.